Bhatia N, Kantor J, Green L, Weiss J, Willson C, Cutler S, Rieger J, Glover DK, Rumney P, Goldenberg G. Results from Part 1 Safety Run-in Period of a 2-part, Phase 2, Multicenter, Open-label, Proof-of-Concept Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of VP-315 in Subjects with Basal Cell Carcinoma. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s260. Available from: https://jofskin.org/33014/index.php/skin/article/view/2333